A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
NCT02351856
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
LMNA-Related Dilated Cardiomyopathy
Interventions
DRUG:
ARRY-371797, p38 inhibitor, oral
Sponsor
Pfizer